New blood test could sniff out lung cancer early

NCT ID NCT06261294

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study collected blood samples from 109 people with and without lung cancer to develop a blood test called OncoSweep Lung Spotlight. The test looks for genetic and other signals in the blood that might indicate lung cancer. Researchers hope this could lead to a simple, non-invasive way to help detect lung cancer earlier.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

OncoSweep Lung Spotlight blood test

What this could lead to

If successful, this could lead to a simple blood test that helps doctors detect lung cancer earlier, potentially improving treatment outcomes.

What could go wrong

This is an early development study with only 109 participants. The test is not yet proven to work in real-world settings and may not be accurate enough for widespread use.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Mackay Memorial Hospital

    Taipei, Zhongshan Dist, 104217, Taiwan